This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Q2 Earnings Top Estimates, Reaffirms View
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter fiscal 2024 results reflect a decline in earnings and sales due to lower consumer demand for certain product categories.
Helen of Troy (HELE) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Helen of Troy (HELE) give a sense of how the business performed in the quarter ended August 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Helen of Troy (HELE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 8.75% and 1.26%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Things to Note Before Helen of Troy's (HELE) Q2 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) second-quarter performance is likely to reflect pressure on some product categories amid lower demand and changes in buying patterns.
Helen of Troy (HELE) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Helen of Troy (HELE) closed at $115.33, marking a -1.96% move from the previous day.
HELE vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
HELE vs. ELF: Which Stock Is the Better Value Option?
COTY's Listing Plans in Paris Look Good: Things Worth Noting
by Zacks Equity Research
Per sources, COTY is moving ahead with its plans to be listed on the Paris Stock Exchange. A day earlier, the company raised its guidance for the first half and fiscal 2024.
Reasons Why You Should Avoid Betting on Sysco (SYY) Now
by Zacks Equity Research
Sysco (SYY) has been encountering slower overall industry market volume growth, product cost inflation, rising operating expenses and a high tax rate.
Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movements.
The J.M. Smucker's (SJM) Solid Pricing Aids Amid Cost Woes
by Zacks Equity Research
The J.M. Smucker (SJM) gains on efficient pricing amid cost inflation. A focus on core priorities and categories like coffee, snacking and pet are working well.
COTY Ups View on Solid Beauty Demand & Product Launch Gains
by Zacks Equity Research
COTY raises guidance for the first half and fiscal 2024 as it gains from solid beauty demand and the success of the recent launch of the Burberry Goddess fragrance.
General Mills (GIS) Q1 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
General Mills' (GIS) first-quarter fiscal 2024 results reflect improved sales, with net price realization being a driver.
The Estee Lauder Companies (EL) Dulls on Cost & Currency Woes
by Zacks Equity Research
The Estee Lauder Companies (EL) is battling volatile inflation levels. The company's international presence exposes it to risks of unfavorable currency rates.
Philip Morris (PM) Smoke-Free Unit Solid, Cigarette Volumes Low
by Zacks Equity Research
Philip Morris (PM) is positioned to continue benefiting from its smoke-free products and pricing strategy amid low cigarette volumes.
Hain Celestial (HAIN) Stock Falls 40.3% YTD: Here's Why
by Zacks Equity Research
Hain Celestial (HAIN) grapples with several headwinds. Sluggishness in the company's North American unit is an added deterrent.
Are Consumer Staples Stocks Lagging Helen of Troy (HELE) This Year?
by Zacks Equity Research
Here is how Helen of Troy (HELE) and Ingredion (INGR) have performed compared to their sector so far this year.
Strength Seen in Inter Parfums (IPAR): Can Its 3.5% Jump Turn into More Strength?
by Zacks Equity Research
Inter Parfums (IPAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Inter Parfums (IPAR) Thrives on Favorable Demand, Brand Strength
by Zacks Equity Research
Inter Parfums (IPAR) benefits from the favorable demand for fragrances and a focus on product launches and licensing deals with renowned brands.
Hain Celestial (HAIN) Announces Reimagined Plan to Aid Growth
by Zacks Equity Research
Hain Celestial (HAIN) announces Reimagined strategy, which includes four pillars namely, focus, grow, build and fuel, to drive sustainable growth.
Altria (MO) Is Marching Ahead of the Industry: Will This Stay?
by Zacks Equity Research
Altria (MO) is positioned to keep benefiting from its smoke-free products and pricing strategy. Management targets nearly doubling its smoke-free net revenues to $5 billion by 2028.
Flowers Foods (FLO) Looks Well-Placed on Pricing, Buyouts
by Zacks Equity Research
Flowers Foods (FLO) benefits from its focus on core priorities, gains from pricing and acquisitions amid cost inflation.
Helen of Troy (HELE) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Helen of Troy (HELE) closed the most recent trading day at $117.62, moving +1.49% from the previous trading session.
Helen of Troy (HELE) Gains on Brand Strength & Project Pegasus
by Zacks Equity Research
Helen of Troy (HELE) benefits from its focus on a solid Leadership Brands portfolio. Its Project Pegasus is aimed at expanding operating margins.
Will Kellogg's (K) Strategic Separation Unlock Higher Potential?
by Zacks Equity Research
Kellogg's (K) management gives the official approval for the company's separation into Kellanova and WK Kellogg Co., which is likely to take effect on Oct 2.
Procter & Gamble (PG) Jumps 10% in a Year: What's Ahead?
by Rajani Lohia
Procter & Gamble's (PG) focus on productivity and cost-saving plans to boost margins, along with pricing actions bode well.